Skip to main content
. 2021 Feb 26;5(5):1164–1177. doi: 10.1182/bloodadvances.2020003568

Figure 1.

Figure 1.

Circulating biomarkers separate COVID-19 patients according to disease severity. (A) Heatmap of proteomic data from the cross-sectional cohort, indicating relative protein levels detected in each subject (columns) for all biomarkers tested (rows). Proteins are categorized by biological function. (B) Visualization of the first 2 principal components (PCs) of a PCA of all biomarker data for each subject.